PEOPLE - NHS Quality Improvement Scotland makes appointment:
This article was originally published in Clinica
Executive Summary
Professor Sir Graham Teasdale has been appointed to chair the board of NHS Quality Improvement Scotland for a four-year term. Professor Teasdale has over 25 years of "frontline experience" in the NHS and is, among other things, president of the Royal College of Physicians and Surgeons of Glasgow. NHS-QIS is the counterpart of the National Institute for Health and Clinical Excellence (for the NHS in England and Wales); while it often provides technology usage policy based on NICE decisions, NHS-QIS has also led on key technology areas, such as B-type natriuretic peptide (BNP) testing for cardiac failure, issued in May 2005 (see Clinica No 1156, p 8).
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.